ARCHIVÉ - Lignes directrices pour la prévention et la lutte contre les atteintes méningococciques
Références
- Santé Canada. Lignes directrices pour la lutte contre les atteintes méningococciques. RMTC 1994;20(3):17-27.
- Squires SG, Deeks SL, Tsang RSW. Surveillance accrue des méningococcies invasives au Canada : du 1er janvier 1999 au 31 décembre 2001. RMTC 2004;30(3):17-28.
- Whalen CM, Hockin JC, Ryan A, et coll. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 1995;273:390-94.
- Deeks S, Kertesz D, Ryan A et coll. Surveillance de la méningococcie invasive au Canada, 1995-1996. RMTC 1997;23(16):121-25.
- Squires SG, Pelletier L, Mungai M et coll. Les méningococcies invasives au Canada, du 1er janvier 1997 au 31 décembre 1998. RMTC 2000;26(21):177-82.
- Varughese PV, Carter AO. Maladie méningococcique au Canada. Synthèse de la surveillance jusqu'en 1987. RHMC 1989;15(17):89-96.
- Ashton FE, Ryan JA, Borczyk A et coll. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal serogroup C disease in Canada. J Clin Microbiol 1991;29:2489-93.
- Ragunathan L, Ramsay M, Borrow R et coll. Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report. J Infect 2000;40:74-9.
- De Wals P, Hertoghe L, Borlée-Grimée I et coll. Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect 1981;3(suppl 1):53-61.
- Meningococcal Disease Surveillance Group. Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA 1976;235:261-65.
- Cooke RPD, Riordan T, Jones DM et coll. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1985-1987. Br Med J 1989;298:555-8.
- Hastings L, Stuart J, Andrews N et coll. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational setting. Commun Dis Rep 1997;7(13):R195-R200.
- Kaiser AB, Hennekens CH, Saslaw MS et coll. Seroepidemiology and chemoprophylaxis of disease due to sulfonamide-resistant Neisseria meningitidis in a civilian population. J Infect Dis 1974;130:217-24.
- Jacobson JA, Camargos PAM, Ferreira JT et coll. The risk of meningitis among classroom contacts during an epidemic of meningococcal disease. Am J Epidemiol 1976;104:552-55.
- Feigin RD, Baker CJ, Herwaldt L et coll. Epidemic meningococcal disease in an elementary-school classroom. N Engl J Med 1982;307:1255-57.
- Hudson PJ, Vogt RL, Heun EM et coll. Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak. Pediatr Infect Dis J 1986;5:213-17.
- Pollard AJ, Begg N. Meningococcal disease and healthcare workers [Editorial]. Br Med J 1999;319:1147-48.
- Gehanno J-F, Kohen-Couderc L, Lemeland J-F et coll. Nosocomial meningococcaemia in a physician. Infect Control Hosp Epidemiol 1999;20:564-65.
- Centers for Disease Control and Prevention. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997;46(RR18):1-42.
- Stroffolini T, Rosmini F, Curiano CM. A one year survey of meningococcal disease in Italy. Eur J Epidemiol 1987;3:399-403.
- Olivares R, Hubert B. Clusters of meningococcal disease in France (1987-1988). Eur J Epidemiol 1992;8:737-42.
- Almog R, Block C, Gdalevich M et coll. First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin. Infection 1994;22:69-71.
- Samuelsson S, Hansen ET, Osler M et coll. Prevention of secondary cases of meningococcal disease in Denmark. Epidemiol Infect 2000;124:433-40.
- Dawson SJ, Fey RE, McNulty CA. Meningococcal disease in siblings caused by rifampicin sensitive and rifampicin resistant strains. Commun Dis Public Health 1999;2:215-16.
- Guiver M, Borrow R, Marsh J et coll. Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 2000;28:173-79.
- Newcombe J, Cartwright K, Palmer WH et coll. PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol 1996;34:1637-40.
- Carrol ED, Thomson AP, Shears P et coll. Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch Dis Child 2000;83:271-73.
- British Columbia Ministry of Health. Communicable disease control: invasive meningococcal disease. January 2001.
- Purcell B, Samuelsson S, Hahne SJM et coll. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. Br Med J 2004;328:1339-42.
- Communicable Diseases Network Australia. Guidelines for the early clinical and public health management of meningococcal disease in Australia. Commonwealth of Australia, 2001. ISBN 0 642 50308 7.
- Stuart JM, Gilmore AB, Ross A et coll. Preventing secondary meningococcal disease in health care workers: recommendations of a working group of the PHLS Meningococcus Forum. Communic Dis Pub Health 2001;4(2):102-105.
- Public Health Laboratory Service Meningococcus Forum. Guidelines for public health management of meningococcal disease in the UK. Commun Dis Public Health. 2002;5(3):187-204.
- Comité consultatif national de l'immunisation. Déclaration sur l'utilisation recommandée des vaccins anti- méningococciques. RMTC 2001;27(DCC-6):2-36.
- Healing TD, Hoffman PN, Young SEJ. The infection hazards of human cadavers. Communic Dis Rep CDC Rev 1995;5:R61-R68.
- Santé Canada. Guide de prévention des infections - Pratiques de base et précautions additionnelles visant à prévenir la transmission des infections dans les établissements de santé. RMTC 1999;25(S4):1-145.
- Centers for Disease Control and Prevention. Exposure to patients with meningococcal disease on aircrafts - United States 1999-2001. MMWR 2001;50(23):485-89.
- Kenyon TA, Valway SE, Ihle WW et coll. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996;334:933-38.
- Kristiansen B-E, Knapsbog A-B. Secondary prevention of meningococcal disease. Br Med J 1996;312:591-92.
- DeWals P. Notice concerning the use of a vaccine to control an outbreak of invasive meningococcal infections. On behalf of the Advisory Committee to the ministère de la santé et des Services Sociaux du Québec, 2001.
- Centers for Disease Control and Prevention. Meningococcal disease and college students. MMWR 2000;49(RR07):11-20.
- Schwartz B. Chemoprophylaxis for bacterial infections: principles of an application to meningococcal infections. Rev Infect Dis 1991;13(suppl 2):S170-S173.
- Judson FN, Ehret JM. Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis. Lancet 1984;2:462-1463.
- Schwartz B, Al-Tobaiqi A, Al-Ruwais A et coll. Comparative efficacy of ceftriaxone and rifampin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet 1988;1:1239-42.
- Girgis N, Sultan Y, Frenck RW et al. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization of Neisseria meningitidis. Pediatr Infect Dis J 1998;17(9):816-19.
- Gonzalez de Aledo LA, Garcia MJ. Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin. An Esp Pediatr 2000;53(5):412-17.
- Comité consultatif national de l'immunisation. Déclaration supplémentaire sur les vaccins conjugués contre le méningocoque. RMTC 2003;29(DCC-6):10-11.
- Santé Canada. Vaccin contre le méningoccoque. Dans : Guide canadien d'immunisation, 6e édition. Ottawa : Santé Canada, 2002;181-96. Cat H49-8/2002F.
- Granoff DM, Gupta RK, Belshe RB et coll. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis 1988;178:870-74.
- Richmond P, Kaczmarski E, Borrow R et coll. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis 2000;181:761-64.
- MacLennan J, Obaro S, Deeks J et coll. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. J Infect Dis 2001;183:97-104.
Détails de la page
- Date de modification :